• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Cardiology

Diabetes, stroke, and coronary heart disease associated with increased mortality among Black adults: Jackson Heart Study

byJake EngelandYuchen Dai
October 29, 2022
in Cardiology, Chronic Disease, Public Health
Reading Time: 2 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. The Jackson Heart Study evaluating the association of cardiometabolic conditions with mortality in Black patients demonstrated that diabetes, stroke, and coronary heart disease (CHD) independently were associated with increased risk of all-cause mortality.

2. The risks of all-cause mortality and CHD mortality were increased among patients with all three cardiometabolic conditions compared to any alone.

Evidence Rating Level: 2 (Good)

Study Rundown: Life expectancy differs among Black and White populations, with diabetes, stroke, and coronary heart disease (CHD) shown to be major contributors. The association of these three conditions, independently and collectively, with mortality, has been studied extensively in White populations. However, despite the greater prevalence of these comorbidities in Black populations, there is a lack of data that has explored and quantified the risk in this cohort. Therefore, the prospective cohort Jackson Heart Study (JHS) assessed independent and multiplicative associations of diabetes, stroke, and CHD with all-cause and CHD mortality among Black adults. Patients were included in the study between 2000 and 2004 with follow-up for a median of 15 years through May 31, 2018. In the adjusted model, all-cause mortality was significantly increased in patients with diabetes (HR: 1.50 [95% CI: 1.22-1.85]), stroke (HR: 1.74 [95% CI: 1.24-2.42]), and CHD (HR: 1.59 [95% CI: 1.22-2.08]); the risk was greatest among those with all three conditions (HR: 3.68 [95% CI: 1.96-6.93]). Diabetes (HR: 1.95 [95% CI: 0.96-3.97]) or stroke (HR: 1.31 [95% CI: 0.31-5.59]) alone were not associated with an increased risk of CHD mortality. However, CHD alone (HR: 3.51 [95% CI: 1.56-7.90]) was associated with a significantly increased risk of CHD mortality. Additionally, the association of all three cardiometabolic multi-morbidities had the highest risk of CHD mortality (HR: 13.52 [95% CI: 3.38-54.12]). Overall, the JHS study demonstrated that Black patients with cardiometabolic conditions have a significantly increased risk of mortality, with the greatest risk among those with all three risk factors. This study was strengthened by its large Black cohort with greater than 15 years of follow-up. However, one limitation of this study is that it was confined to one geographic area and may not be generalizable to all Black adults in the United States.

Click to read the study in JAMA (Journal of the American Medical Association)

Relevant Reading: Association of cardiometabolic multimorbidity with mortality

RELATED REPORTS

AI cardiac MRI analysis marginally outperforms clinicians in predicting all-cause mortality

2MM: Pharma Roundup – First DNA therapy approved which could reduce airway surgeries, novel siRNA targets dual lipid pathways, GLP-1s outperform metformin in prediabetes, and Zolgensma tumor risks under FDA review

FDA approvedFor stroke: Sunharbo (asundexian), Nov 9, 2026→

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: all-cause mortalityBlack patientscoronary heart diseasediabetesJackson Heart Study
Previous Post

#VisualAbstract: Continuous glucose monitoring in type 1 diabetes results in improved blood glucose levels

Next Post

Variation in prostate cancer screening rates associated with subsequent metastatic prostate cancer incidence

RelatedReports

Physical activity collage: an engraved bicycle, a water bottle lying on its side and a path of flat stepping stones
Artificial Intelligence

AI cardiac MRI analysis marginally outperforms clinicians in predicting all-cause mortality

November 19, 2026
A variety of pharmaceutical items including a vial, capsule, molecule model, pill blister pack, petri dish with a pipette, and a graph, symbolizing drug development.
Pharma Roundup

2MM: Pharma Roundup – First DNA therapy approved which could reduce airway surgeries, novel siRNA targets dual lipid pathways, GLP-1s outperform metformin in prediabetes, and Zolgensma tumor risks under FDA review

November 9, 2026
A woman gently holding her shoulder, reflecting a contemplative mood, with art elements representing healing and growth around her.
Chronic Disease

Increased alcohol consumption among post-menopausal women is associated with higher mortality

October 28, 2026
An illustration featuring a heart within a house, with a stethoscope, a scale, and medication, symbolizing heart failure home hospital care.
Cardiology

Prognostic associations of anthropometric indices vary by clinical outcomes

September 28, 2026
Next Post
Collage on the PSA blood test: an engraved bladder and prostate, a capped blood tube, a balance scale and a blank calendar

Variation in prostate cancer screening rates associated with subsequent metastatic prostate cancer incidence

2 Minute Medicine Rewind October 31, 2022

Relationship between medication adherence, religiosity and spirituality amongst patients with cardiovascular disease is inconclusive

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • In online experiment, AI disagreement increased perceived laziness and uncertainty toward an LLM-simulated doctor
  • Long-term use of mometasone (Asmanex) in adults with sickle cell disease without formal diagnosis of asthma may worsen disease activity
  • Few patients had ED lumbar CT or MRI within 30 days after low-acuity back-pain radiography at urgent care centers
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.